Monroe Capital has provided a $46.5 million unitranche credit facility to support the recapitalization of Conisus by Webster Capital.
Conisus provides scientific-oriented promotional marketing and education services to biopharmaceutical companies to assist in the promotion and education of oncology drugs and therapies. The company is based in Atlanta (www.conisus.com).
Monroe Capital is a specialty finance company providing senior and junior debt to middle-market companies. The firm specializes in originating, structuring and providing one-stop financings. Investment types include senior and junior secured debt as well as bridge loans, acquisition facilities, mezzanine or last-out secured loans and equity co-investments. Monroe Capital is based in Chicago (www.monroecap.com).
Webster Capital invests in branded consumer, business- to-business, and healthcare services companies with EBITDAs from $3 million to $15 million and transaction values less than $100 million. The firm is currently investing Webster Capital II, a $205 million fund which closed in 2007. Webster was founded in 2003 and is based in Waltham, MA (www.webstercapital.com).
© 2013 PEPD • Private Equity’s Leading News Magazine • 1-8-13